Preclinical data shows strong, durable, and precise repression of HBV DNA acrossin vitro and in vivo models, offering a possible pathway to a functional cure DURHAM, NC and SEATTLE, WA (November 19, 2024) – Leading epigenome editing company Tune Therapeutics showcased new data yesterday at the American Association for the Study of Liver Diseases (AASLD) […]